Robert McDowell

2019

In 2019, Robert McDowell earned a total compensation of $2.8M as Chief Scientific Officer at MyoKardia, a 10% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$168,000
Option Awards$1,451,290
Salary$410,194
Stock Awards$794,178
Other$1,000
Total$2,824,662

McDowell received $1.5M in option awards, accounting for 51% of the total pay in 2019.

McDowell also received $168K in non-equity incentive plan, $410.2K in salary, $794.2K in stock awards and $1K in other compensation.

Rankings

In 2019, Robert McDowell's compensation ranked 4,324th out of 13,971 executives tracked by ExecPay. In other words, McDowell earned more than 69.1% of executives.

ClassificationRankingPercentile
All
4,324
out of 13,971
69th
Division
Manufacturing
1,587
out of 5,701
72nd
Major group
Chemicals And Allied Products
555
out of 2,200
75th
Industry group
Drugs
467
out of 1,886
75th
Industry
Pharmaceutical Preparations
355
out of 1,398
75th

Pay ratio

Robert McDowell's Pay$2,824,662
Median Employee's Pay$268,172
Pay Ratio

11

to 1

In 2019, the annual total compensation of Robert McDowell was $2,824,662.

The annual total compensation of the median employee at MyoKardia was $268,172.

The ratio of Robert McDowell's pay to the pay of median employee was therefore 11 to one.

Source: SEC filing on April 24, 2020.

McDowell's colleagues

We found five more compensation records of executives who worked with Robert McDowell at MyoKardia in 2019.

2019

Tassos Gianakakos

MyoKardia

Chief Executive Officer

2019

William Fairey

MyoKardia

Executive Vice President, Chief Commercial Officer

2019

June Lee

MyoKardia

Executive Vice President, Chief Development Officer

2019

Jake Bauer

MyoKardia

Chief Business Officer

2019

Taylor Harris

MyoKardia

Chief Financial Officer

News

In-depth

You may also like